3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
50
Pancreatic Neoplasms
33
Prostatic Neoplasms
31
Brain Neoplasms
28
Lung Neoplasms
26
Neoplasm Metastasis
24
Melanoma
21
Carcinoma, Hepatocellular
20
Breast Neoplasms
17
Carcinoma, Renal Cell
12
Colorectal Neoplasms
11
Squamous Cell Carcinoma of Head and Neck
10
Neoplasms
9
Small Cell Lung Carcinoma
7
Urinary Bladder Neoplasms
5
Recurrence
5
Head and Neck Neoplasms
5
Glioblastoma
5
Adenocarcinoma of Lung
5
Sarcoma
4
Liver Neoplasms
4
Kidney Neoplasms
4
Uterine Cervical Neoplasms
3
NSCLC
3
Clear-cell metastatic renal cell carcinoma
3
Cholangiocarcinoma
3
Uveal Melanoma
2
Unresectable Locally Recurrent Rectal Cancer
2
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
2
Interventions
pembrolizumab
4
Docetaxel
3
Cisplatin
3
Cetuximab
3
Gefitinib
2
Cyclophosphamide
2
zalutumumab
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
atezolizumab
1
advexin
1
abemaciclib
1
Vorinostat
1
Radiotherapy
1
Radiosurgery
1
Oxaliplatin
1
Nivolumab
1
Imatinib Mesylate
1
Everolimus
1
Erlotinib Hydrochloride
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasms, Squamous Cell
×
Radiosurgery
×
Clear all
NCT04435938
2020-12-02
SHINE
McMaster University
Phase 2
Unknown
38 enrolled